Orchard raises $150m to develop gene therapiesBiotech has trio of rare disease therapies Share XOrchard raises $150m to develop gene therapieshttps://pharmaphorum.com/news/orchard-raises-150m-to-develop-gene-therapies/
Orchard’s gene therapy gains UK ‘promising innovative medicine’ statusA UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy. Share XOrchard’s gene therapy gains UK ‘promising innovative medicine’ statushttps://pharmaphorum.com/news/orchards-gene-therapy-gains-uk-promising-innovative-medicine-status/